Inclusion Criteria:

- Patient with a planned admission for at least 24 hours for highly emetogenic or
moderately emetogenic chemotherapy at Lucile Packard Children's Hospital or Packard
El Camino.

- Planned to undergo at least 2 more cycles of chemotherapy.

- Can include but not limited to: children with high risk ALL, AML, Ewing's Sarcoma,
Osteosarcoma

- History of vomiting with prior cycles of chemotherapy (2 episodes of emesis at
minimum) despite use of conventional antiemetic medications.

- Age 8-21.

- Parent must be able to understand and willing to sign written informed consent
document.

Exclusion Criteria:

- Prior knowledge of acupuncture or experience with acupuncture or acupressure.

- There will be no restrictions regarding use of other Investigational Agents.

- Comorbid Diseases:

- Diagnosis of any cardiac condition (cardiomyopathy, arrhythmia, pacemaker
placement).

- Any diagnosis requiring pediatric intensive care unit admission.

- Patients with brain tumor, brain metastasis (these patients often require
radiation and surgery in addition to chemotherapy which may confound the
results)

- Concomitant radiation therapy during current chemotherapy cycle.

- Developmental delay patients with allergy to tape or leads will be excluded from
the study.

- Pregnant patients will be excluded from the study.

- Cancer survivors will not be excluded from the study as long as they are undergoing
chemotherapy treatment for their current cancer therapy.

- HIV-positive patients will not be excluded.